Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs ElleS

AM Rx
Graded #491

Lower grade

vs+6.399999999999999
ElleS
Graded #424

Higher grade

The verdict

ElleS takes it — 56/100 to 49.6/100.

ElleS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElleS (ElleS Inc.) is a comprehensive compounded telehealth service.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +5
50
45
Dose & formulationAM Rx +14
65
51
Clinical oversightElleS +37
41
78
Labs & monitoringElleS +12
49
61
FulfillmentElleS +10
58
68
Contract termsEven
20
20
AM Rx · left barElleS · right bar

The numbers

MetricAM RxElleS
WeighScore49.6/10056/100
GradeCC
Scorecard rank#491#424
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
ElleS

Graded #424 · C

Strengths

  • Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
  • Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
  • Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
  • Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)

Where it loses points

  • Pricing not shown publicly — products and costs appear only after the intake flow
  • Sold as 3- and 6-month packages rather than simple monthly plans
  • Compounding pharmacy partner not named ('made in licensed US facilities')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard